By Josh White
Date: Tuesday 27 Feb 2024
(Sharecast News) - Fusion Antibodies announced the receipt of its first purchase order under a master services agreement on Tuesday, which it agreed with a prominent diagnostics company on 14 February.
By Josh White
Date: Wednesday 14 Feb 2024
(Sharecast News) - Pre-clinical antibody specialist Fusion Antibodies announced a conditional fundraising of £1.38m before expenses on Wednesday, to help it target mo re industry conferences and customers and generate further supporting data.
By Josh White
Date: Thursday 01 Feb 2024
(Sharecast News) - Preclinical antibody discovery specialist Fusion Antibodies announced the successful receipt of a research and development tax credit from HMRC on Thursday.
Currency | UK Pounds |
Share Price | 3.35p |
Change Today | -0.050p |
% Change | -1.47 % |
52 Week High | 40.00 |
52 Week Low | 3.20 |
Volume | 869,509 |
Shares Issued | 95.37m |
Market Cap | £3.19m |
RiskGrade | 464 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:29 | 29 @ 3.38p |
16:28 | 29 @ 3.38p |
16:13 | 29 @ 3.38p |
16:09 | 75,000 @ 3.32p |
15:28 | 29 @ 3.40p |
Chair | Simon Gordon Douglas |
CEO | Adrian Kinkaid |
You are here: research